265 related articles for article (PubMed ID: 30923703)
61. Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.
Liu F; Li S
Front Pharmacol; 2022; 13():934396. PubMed ID: 36034860
[TBL] [Abstract][Full Text] [Related]
62. Clinical trials using molecular stratification of pediatric brain tumors.
Hanz SZ; Adeuyan O; Lieberman G; Hennika T
Transl Pediatr; 2020 Apr; 9(2):144-156. PubMed ID: 32477915
[TBL] [Abstract][Full Text] [Related]
63. Medulloblastoma: molecular pathways and histopathological classification.
Borowska A; Jóźwiak J
Arch Med Sci; 2016 Jun; 12(3):659-66. PubMed ID: 27279861
[TBL] [Abstract][Full Text] [Related]
64.
Li Z; Langhans SA
Front Oncol; 2021; 11():620831. PubMed ID: 33869004
[TBL] [Abstract][Full Text] [Related]
65. The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review.
Nafe R; Hattingen E
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626776
[TBL] [Abstract][Full Text] [Related]
66. Application of Small Epigenetic Modulators in Pediatric Medulloblastoma.
Zwergel C; Romanelli A; Stazi G; Besharat ZM; Catanzaro G; Tafani M; Valente S; Mai A
Front Pediatr; 2018; 6():370. PubMed ID: 30560106
[TBL] [Abstract][Full Text] [Related]
67. Orphan noncoding RNAs: novel regulators and cancer biomarkers.
Teng M; Liu LY; Hua JT; Chen S; He HH
Ann Transl Med; 2019 Mar; 7(Suppl 1):S21. PubMed ID: 31032301
[No Abstract] [Full Text] [Related]
68. Noncoding RNAs and Base Modifications: Epigenomic Players Implicated in Neurological Disorders and Tumorigenesis.
Li Y; Park C; Jiang H; Li X; Vellón L
Int J Genomics; 2018; 2018():9016018. PubMed ID: 30402455
[No Abstract] [Full Text] [Related]
69. Correction to: Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.
Lee B; Mahmud I; Pokhrel R; Murad R; Yuan M; Stapleton S; Bettegowda C; Jallo G; Eberhart CG; Garrett T; Perera RJ
Acta Neuropathol Commun; 2022 Apr; 10(1):58. PubMed ID: 35459192
[No Abstract] [Full Text] [Related]
70. CORRIGENDUM for "Emerging Roles for Noncoding RNAs in Autoimmune Thyroid Disease".
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32679588
[No Abstract] [Full Text] [Related]
71. Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness.
Esposito R; Lanzós A; Uroda T; Ramnarayanan S; Büchi I; Polidori T; Guillen-Ramirez H; Mihaljevic A; Merlin BM; Mela L; Zoni E; Hovhannisyan L; McCluggage F; Medo M; Basile G; Meise DF; Zwyssig S; Wenger C; Schwarz K; Vancura A; Bosch-Guiteras N; Andrades Á; Tham AM; Roemmele M; Medina PP; Ochsenbein AF; Riether C; Kruithof-de Julio M; Zimmer Y; Medová M; Stroka D; Fox A; Johnson R
Nat Commun; 2023 Sep; 14(1):5463. PubMed ID: 37673946
[No Abstract] [Full Text] [Related]
72. Medulloblastoma in the age of molecular subgroups: a review.
Juraschka K; Taylor MD
J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
[TBL] [Abstract][Full Text] [Related]
73. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M
J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029
[TBL] [Abstract][Full Text] [Related]
74. EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter.
Yildiz CB; Kundu T; Gehrmann J; Koesling J; Ravaei A; Wolff P; Kraft F; Maié T; Jakovcevski M; Pensold D; Zimmermann O; Rossetti G; Costa IG; Zimmer-Bensch G
Epigenetics Chromatin; 2023 Oct; 16(1):42. PubMed ID: 37880732
[TBL] [Abstract][Full Text] [Related]
75. The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review.
Martinez de Estibariz I; Jakjimovska A; Illarregi U; Martin-Guerrero I; Gutiérrez-Camino A; Lopez-Lopez E; Bilbao-Aldaiturriaga N
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835380
[TBL] [Abstract][Full Text] [Related]
76. RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective.
Laneve P; Tollis P; Caffarelli E
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638636
[TBL] [Abstract][Full Text] [Related]
77. Identification and Functional Characterization of Novel MYC-Regulated Long Noncoding RNAs in Group 3 Medulloblastoma.
Rea J; Carissimo A; Trisciuoglio D; Illi B; Picard D; Remke M; Laneve P; Caffarelli E
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359754
[TBL] [Abstract][Full Text] [Related]
78. The Non-coding Side of Medulloblastoma.
Laneve P; Caffarelli E
Front Cell Dev Biol; 2020; 8():275. PubMed ID: 32528946
[TBL] [Abstract][Full Text] [Related]
79. Long Noncoding RNAs: Emerging Players in Medulloblastoma.
Laneve P; Rea J; Caffarelli E
Front Pediatr; 2019; 7():67. PubMed ID: 30923703
[TBL] [Abstract][Full Text] [Related]
80. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
